Which of the following drugs required a dose adjustment in patient during radiotherapy in order to present radiation toxicity ?
**Core Concept**
The question is testing the understanding of drug interactions and pharmacokinetics in the context of radiotherapy. Radiation therapy can alter the pharmacokinetics of certain drugs, leading to toxicity or reduced efficacy. This is particularly relevant for medications that are metabolized by enzymes sensitive to radiation.
**Why the Correct Answer is Right**
The correct answer is likely a drug that undergoes metabolism via the cytochrome P450 enzyme system, particularly those that are metabolized by CYP2D6 or CYP3A4. Radiation therapy can induce or inhibit these enzymes, leading to changes in drug concentrations and increased toxicity. For example, certain chemotherapeutic agents like irinotecan (a CYP3A4 substrate) may require dose adjustments during radiotherapy to prevent increased toxicity.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not a well-known example of a drug that requires dose adjustments during radiotherapy.
* **Option B:** This option may be a plausible choice, but it is not the most widely recognized example of a drug that requires dose adjustments during radiotherapy.
**Clinical Pearl / High-Yield Fact**
It is essential to be aware of the potential for drug interactions during radiotherapy, particularly for medications that undergo significant metabolism via the cytochrome P450 enzyme system. A thorough review of the patient's medication regimen and potential interactions with radiation therapy is crucial to prevent toxicity and optimize treatment outcomes.
**Correct Answer:** C.